December 12, 2016 / 12:09 PM / 7 months ago

BRIEF-Bayer and Versant Ventures announce the launch of BlueRock Therapeutics

1 Min Read

Dec 12 (Reuters) - Bayer AG :

* Bayer and Versant Ventures join forces to launch stem cell therapy company BlueRock Therapeutics with $225 million series A financing Source text - bit.ly/2hEcHOj Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below